These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 20688250)

  • 1. Pauci-immune necrotizing glomerulonephritis.
    Rutgers A; Sanders JS; Stegeman CA; Kallenberg CG
    Rheum Dis Clin North Am; 2010 Aug; 36(3):559-72. PubMed ID: 20688250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rapidly progressive ANCA-negative glomerulonephritis in the course of pauci immune microscopic vasculitis with hemolytic anemia probable in the course of Wilson's disease].
    Wieczorek-Surdacka E; Kaczmarczyk I; Jasik P; Przepiórkowska-Hoyer B; Sułowicz W
    Przegl Lek; 2011; 68(2):123-5. PubMed ID: 21751523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective.
    Falk RJ; Nachman PH; Hogan SL; Jennette JC
    Semin Nephrol; 2000 May; 20(3):233-43. PubMed ID: 10855933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANCA-Associated Vasculitis: Core Curriculum 2020.
    Geetha D; Jefferson JA
    Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pauci-immune crescentic glomerulonephritis.
    Gupta RK
    Indian J Pathol Microbiol; 2003 Jul; 46(3):357-66. PubMed ID: 15025274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ANCA-associated forms of vasculitis].
    Helmchen U; Kneissler U; Prall F
    Verh Dtsch Ges Pathol; 1996; 80():38-45. PubMed ID: 9065053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal histology in pauci-immune rapidly progressive glomerulonephritis: 8-year retrospective study.
    Minz RW; Chhabra S; Joshi K; Rani L; Sharma N; Sakhuja V; Duggal R; Pasricha N
    Indian J Pathol Microbiol; 2012; 55(1):28-32. PubMed ID: 22499296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-neutrophil cytoplasm-associated glomerulonephritis.
    Morgan MD; Harper L; Williams J; Savage C
    J Am Soc Nephrol; 2006 May; 17(5):1224-34. PubMed ID: 16624931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and outcomes of ANCA-associated renal vasculitis.
    Seck SM; Dussol B; Brunet P; Burtey S
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):301-5. PubMed ID: 22382223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANCA-negative pauci-immune renal vasculitis: histology and outcome.
    Eisenberger U; Fakhouri F; Vanhille P; Beaufils H; Mahr A; Guillevin L; Lesavre P; Noël LH
    Nephrol Dial Transplant; 2005 Jul; 20(7):1392-9. PubMed ID: 15855209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters?
    Sharma A; Nada R; Naidu GS; Minz RW; Kohli HS; Sakhuja V; Gupta KL; Rathi M
    Int J Rheum Dis; 2016 Jan; 19(1):74-81. PubMed ID: 26269223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An index for renal outcome in ANCA-associated glomerulonephritis.
    Vergunst CE; van Gurp E; Hagen EC; van Houwelingen HC; Hauer HA; Noël LH; Waldherr R; Ferrario F; van der Woude FJ; Bruijn JA; Bajema IM;
    Am J Kidney Dis; 2003 Mar; 41(3):532-8. PubMed ID: 12612975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ANCA-associated vasculitis].
    Sinico RA; Sabadini E; Boeri R; Radice A
    G Ital Nefrol; 2002; 19(2):125-36. PubMed ID: 12195410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive therapy and clinical evolution in forty-nine patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis.
    Kokolina E; Alexopoulos E; Dimitriadis C; Vainas A; Giamalis P; Papagianni A; Ekonomidou D; Memmos D
    Ann N Y Acad Sci; 2005 Jun; 1051():597-605. PubMed ID: 16127000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of ANCA associated systemic necrotizing vasculitides].
    Guillevin L
    Bull Acad Natl Med; 2008; 192(6):1175-87; discussion 1188. PubMed ID: 19235481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANCA-positive pauci-immune rapidly progressive glomerulonephritis and the nephrotic syndrome.
    Jabur WL; Saeed HM
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):526-30. PubMed ID: 20427883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kidney involvement in systemic necrotizing vasculitis].
    Chauveau D; Guittard J; Mehrenberger M; Pourrat J
    Rev Prat; 2008 Mar; 58(5):499-506. PubMed ID: 18524106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome.
    Naidu GS; Sharma A; Nada R; Kohli HS; Jha V; Gupta KL; Sakhuja V; Rathi M
    Rheumatol Int; 2014 Dec; 34(12):1721-7. PubMed ID: 24838685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical course and outcome predictors in pauci-immune ANCA-positive renal-limited vasculitis.
    Rupcić V; Jakić M; Rupcić V; Vizjak V; Fijacko M
    Acta Clin Croat; 2011 Dec; 50(4):475-83. PubMed ID: 22649876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.